Fundraising FoxArk Biosciences
Shanghai, CN · 3 known investors
Find your way into Ark Biosciences
Sign up to find every way you can get introduced to Ark Biosciences
- Your email: who you already know at Ark Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Ark Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.
Investors · 3
Decheng Capitallisted by Decheng CapitalMenlo Park
How we know: Decheng Capital's portfolio page · the VCSheet dataset · Not right? Tell us
YuanBio Venture Capitallisted by YuanBio Venture CapitalSuzhou · $3M – $73M
How we know: YuanBio Venture Capital's portfolio page · Not right? Tell us
Qiming Venture PartnersreportedBeijing · $5M – $134M
How we know: funding news · Not right? Tell us
Frequently asked questions
- What does Ark Biosciences do?
- Ark Biosciences is a biopharmaceutical company developing small molecule drugs for infectious diseases, respiratory conditions, neuropsychiatric disorders, and rare diseases. The company has multiple drug candidates in clinical development, with products licensed from partners including Roche and others.
- Who are Ark Biosciences's investors?
- Ark Biosciences's investors include Decheng Capital, YuanBio Venture Capital, Qiming Venture Partners.
- Where is Ark Biosciences headquartered?
- Ark Biosciences is headquartered in Shanghai, CN.